症例集 - JBC Live Demonstration 2024

Target lesion : LM bifurcation (111)

• 80’s year-old-female
• DxAngina Pectoris
• Risk factorDM,DL
• Clinical course

  2024/4

  Admission for AHF
  CAG #2 100%, #5 90%, #6 50%, #7 50%, #11 50%, #13 75%

  2024/5

  PCI:#2 100%→25%(DCB 2.5×25mm)

  2024/9

  Coronary CT LAD FFR 0.54, LCx FFR <0.5

• TTEEF 34%, Dd/Ds 59/52mm, Asynergy inferior sH
• Renal functionCr 0.88mg/dl , eGFR 46.4
• HBR2 major, 3 minor
• Syntax24
• Syntax ⅡPCI 54.0/41.1%, CABG 43.1/19.2% (CABG recommend)

Target lesion : LM bifurcation (110)

• 50’s year-old-male
• DxAngina Pectoris
• Risk factorDM, DL, Smoking
• Clinical course

  2024/8

  Admission for STEMI
  CAG #4PL 100%, #5 75%, #6 90%, #7 25%, #13 25%
  emPCI #4 PL 100%→0% (DES 3.0×19mm)

  2024/9

  Coronary CT LAD FFR 0.66

• TTEEF 52%, Dd/Ds 55/43mm, Asynergy inferior sH
• Renal functionCr 0.74mg/dl , eGFR 87.8
• HBRNone
• Syntax20
• Syntax ⅡPCI 16.7/2.3%, CABG 17.5/2.4% (CABG or PCI)

Target lesion : LM bifurcation (110)

• 80’s year-old-male
• DxSilent myocardial ischemia
• Risk factorHT, DM, Past smoking
• Clinical course

  2024/8

  Admission for NSTEMI
  CAG #1 90%, #2 99%delay, #5 75%, #6 90%, #7 50%, #14 50%
  emPCI RCA 99%→0% (DES 4.0×28mm, 2.5×48mm)

• TTEEF 49%, Dd/Ds 54/42mm, Asynergy inferior H, Mild AS
• Renal functionCr 0.94mg/dl , eGFR 58.4
• HBR0 major, 3 minor
• Syntax27
• Syntax ⅡPCI 48.7/28.8%, CABG 57.6/51.2% (CABG or PCI)

Target lesion : LAD-Dx bifurcation (101)(011)

• 60’s year-old-male
• DxSilent myocardial ischemia
• Risk factorHT, DL, DM, Smoking
• Clinical course

  2024/3

  CLTI EVT for Lt ATA/PTA CTO→25%

  2024/9

  minor amputation

  2024/11

  CAG #2 50%, #3 75%, #4PD 75%, #4PL 50%, #5 50%, #6 75%, #7 75%, #8 75%, #9 75%, #10 75%, #11 50%, #13 75%

• FFR LAD 0.55, LCx 0.69, RCA 0.58
• TTEEF 69%, Dd/Ds 39/24mm, No Asynergy
• Renal functionCr 1.13mg/dl , eGFR 52.2
• HBR0 major, 1 minor
• Syntax 61
• Syntax Ⅱ PCI 48.1/27.5%, CABG 38.1/13.0% (CABG or PCI)